Stilley William B. III
SEC CIK 1718069 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADIL | ADIAL PHARMACEUTICALS, INC. | Dir | 1.26M | $55.0K | — | 4 | 2021-11-29 | 2023-05-23 |
Most active insiders at ADIL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coastlands Capital LP | 10% | $106.3K | — |
| 2 | Shah Vinay | CFO | — | — |
| 3 | Davidson Matt | Chief Development Off, Dir | — | — |
| 4 | Gilliland Robertson H. | Dir | — | — |
| 5 | Schuyler Kevin | Dir | — | — |
| 6 | Goodman Tony | COO, Dir | — | — |
| 7 | Claiborne Cary J | CEO, Dir | — | — |
Stilley William B. III made no open-market trades at ADIL in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-25 | 2023-05-23 | ADIL | ADIAL PHARMACEUTICALS, INC. | Stilley William B. III | Dir | A - Grant | $0.00 | +240.8K | 1.26M | +24% | $0 |
| 2023-01-03 | 2022-12-30 | ADIL | ADIAL PHARMACEUTICALS, INC. | Stilley William B. III | Dir | D - Sale to Iss | $0.00 | -166.7K | 1.02M | -14% | $0 | |
| 2022-02-25 | 2022-02-23 | ADIL | ADIAL PHARMACEUTICALS, INC. | Stilley William B. III | CEO, Dir | A - Grant | $0.00 | +250.0K | 1.19M | +27% | $0 | |
| M | 2021-12-01 | 2021-11-29+ | ADIL | ADIAL PHARMACEUTICALS, INC. | Stilley William B. III | CEO, Dir, 10% | P - Purchase | $2.67 | +20.6K | 927.0K | +2% | +$55.0K |
Purchase Sale Sale after option exercise All abbreviations